Cargando…
Clinical Course, Imaging Characteristics, and Therapeutic Response in Myelin Oligodendrocyte Glycoprotein Antibody Disease: A Case Series
Myelin oligodendrocyte glycoprotein (MOG) antibody disease is a novel central nervous system autoimmune disorder which forms part of aquaporin 4 (AQP-4) negative, neuromyelitis optica (NMO) spectrum disorder. It has a distinct clinical profile, neuroimaging features and courses from AQP-4 positive N...
Autores principales: | James, Joe, Jose, James, Gafoor, V. Abdul, Smita, B., Balaram, Neetha, Ramachandran, Aparna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd.
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055612/ https://www.ncbi.nlm.nih.gov/pubmed/32140030 http://dx.doi.org/10.1055/s-0040-1701371 |
Ejemplares similares
-
Anti-GAD65 Related Neurological Disorder Presenting as Isolated Hemiataxia: A New Report with Review of Previously Published Patients
por: Ramachandran, Aparna, et al.
Publicado: (2022) -
Prevalence and Risk Factors of Peripheral Neuropathy in Parkinson's Disease
por: Ramachandran, Aparna, et al.
Publicado: (2022) -
Therapeutic response to rituximab in seropositive neuromyelitis optica: Experience from a tertiary care center in South India
por: James, Joe, et al.
Publicado: (2023) -
Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children
por: Hacohen, Yael, et al.
Publicado: (2015) -
Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
por: Corbali, Osman, et al.
Publicado: (2023)